Drug Shortage Report for TEVA-CANDESARTAN/HCTZ

Last updated on 2017-10-10 History
Report ID 974
Drug Identification Number 02395568
Brand name TEVA-CANDESARTAN/HCTZ
Common or Proper name Hydrochlorothiazide Candesartan Cilexetil
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL
Strength(s) 12.5MG 32MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-11-22
Estimated end date 2017-03-31
Actual end date 2017-09-01
Shortage status Resolved
Updated date 2017-10-10
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-10-10 French Compare
v5 2017-10-10 English Compare
v4 2017-03-14 French Compare
v3 2017-03-14 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare